Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
BioSpace
Wed, 09/27/23 - 11:57 am
AstraZeneca
Bristol Myers Squibb
drug pricing
Inflation Reduction Act
Medicare
Latest trial win further supports expanded use of Bristol Myers’ Opdivo in lung cancer
BioPharma Dive
Sun, 09/24/23 - 08:54 pm
Bristol Myers Squibb
Opdivo
non-small cell lung cancer
clinical trials
Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement
Fierce Pharma
Mon, 09/18/23 - 12:30 pm
Samsung BioLogics
Bristol Myers Squibb
drug manufacturing
antibodies
Bristol Myers plans to double experimental treatments to expand research pipeline
Yahoo/Reuters
Thu, 09/14/23 - 11:19 am
Bristol Myers Squibb
clinical trials
R&D
Xspray, seeking FDA approval for its Sprycel competitor, settles patent lawsuit with BMS
Fierce Pharma
Tue, 09/12/23 - 07:08 pm
Xspray Pharma
FDA
Sprycel
Bristol Myers Squibb
Dasynoc
Bristol Myers Squibb reports results from Phase II study of BMS-986278
Clinical Trials Arena
Mon, 09/11/23 - 12:33 pm
Bristol Myers Squibb
clinical trials
progressive pulmonary fibrosis
BMS-986278
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Reuters
Thu, 09/7/23 - 10:57 pm
Bristol Myers Squibb
Celgene
patents
legal
Pomalyst
BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst
Fierce Biotech
Thu, 08/31/23 - 10:55 am
Bristol Myers Squibb
Revlimid
Pomalyst
Multiple Myeloma
mezigdomide
Bristol Myers gets key FDA approval for bone marrow disease drug
BioPharma Dive
Wed, 08/30/23 - 09:54 am
Bristol Myers Squibb
FDA
Reblozyl
myelodysplastic syndromes
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
BMS backs $255m round for contract cell maker Cellares
Pharmaphorum
Thu, 08/24/23 - 10:22 am
Cellares
funding
cell therapy
Bristol Myers Squibb
Fierce Biotech Layoff Tracker 2023: Bayer-bought BlueRock makes cuts; Alaunos lets go 60% of teams
Fierce Biotech
Fri, 08/18/23 - 10:28 am
layoffs
Alaunos Therapeutics
BlueRock Therapeutics
Thermo Fisher
Bristol Myers Squibb
Atreca
Galera Therapeutics
Inovio
Salarius Pharmaceuticals
Karyopharm Therapeutics
Intergalatic Therapeutics
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Another round of layoffs hits BMS, with 100+ people impacted after earnings miss
Fierce Pharma
Mon, 08/14/23 - 11:33 am
Bristol Myers Squibb
layoffs
BMS debuts ‘We Are Bristol Myers Squibb’ video
Medical Marketing and Media
Tue, 08/8/23 - 10:38 pm
Bristol Myers Squibb
branding
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
Eliquis: the cardio drug that cannot be beat
EP Vantage
Fri, 08/4/23 - 10:14 am
Bristol Myers Squibb
Eliquis
generics
Bristol Myers, BeiGene end legacy Celgene deal with settlement years after China ban
Fierce Pharma
Thu, 08/3/23 - 11:22 am
Bristol Myers Squibb
BeiGene
Celgene
Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for $510M
Fierce Pharma
Tue, 08/1/23 - 12:02 pm
Bristol Myers Squibb
AstraZeneca
cancer immunotherapy
legal
patents
Patent Infringement
Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters
Mon, 07/31/23 - 10:12 am
injectables
cancer
JNJ
Bristol Myers Squibb
Halozyme
drug pricing
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »